Absolute Risk of Progression to Cognitive Impairment Based on Plasma Phosphorylated Tau 217, Age, Sex, and APOE ε4

队列 痴呆 医学 内科学 载脂蛋白E 阿尔茨海默病神经影像学倡议 生物标志物 危险系数 肿瘤科 队列研究 比例危险模型 认知障碍 疾病 认知功能衰退 阿尔茨海默病 纵向研究 神经影像学 老年学 观察研究 病例对照研究 前瞻性队列研究 中枢神经系统疾病 退行性疾病 流行病学 认知 年轻人 内分泌学 曲线下面积
作者
Alicia Algeciras‐Schimnich,Mingzhao Hu,Stephen D. Weigand,Terry M. Therneau,Heather J. Wiste,Michael E Griswold,Daniel J. Figdore,Joshua A. Bornhorst,Prashanthi Vemuri,David S. Knopman,Jonathan Graff‐Radford,Ronald C. Petersen,Clifford R. Jack,Alzheimer’s Disease Neuroimaging Initiative,Maison Abu Raya,Ala Abusalim,Mara Acevedo,Skieff Acothley,Allison Acree,Olusegun Adegoke
出处
期刊:JAMA Neurology [American Medical Association]
标识
DOI:10.1001/jamaneurol.2026.4292
摘要

Importance: Alzheimer disease (AD) pathology can be detected years before symptom onset, but some individuals who are biomarker positive and cognitively unimpaired (CU) remain asymptomatic. Objective: To estimate 5- and 10-year absolute risks of mild cognitive impairment (MCI) and dementia using continuous plasma phosphorylated tau 217 (p-tau217) and p-tau217/amyloid β 42 (Aβ42). Design, Setting, and Participants: This cohort study included participants from the Mayo Clinic Study of Aging (MCSA) and the Alzheimer's Disease Neuroimaging Initiative (ADNI). Participants were CU individuals aged 60 to 90 years with baseline Fujirebio Lumipulse plasma p-tau217 measurements, APOE genotyping, and longitudinal clinical follow-up. The MCSA is a population-based longitudinal cohort of residents in Olmsted County, Minnesota; ADNI is a multicenter observational cohort. MCSA data were ascertained from October 2008 to September 2025; ADNI data from September 2005 to January 2026. Exposures: Age, sex, APOE ε4, p-tau217, and p-tau217/Aβ42. Main Outcomes and Measures: Transition from CU to MCI and dementia estimated using continuous-time multistate models. Results: In the MCSA cohort (n = 1644), the median (IQR) age was 72 (66-79) years; 804 participants (49%) were female and 840 (51%) were male. In the ADNI cohort (n = 534), the median (IQR) age was 72 (68-77) years; 297 participants (56%) were female and 237 (44%) were male. A p-tau217 of 0.324 pg/mL vs 0.072 pg/mL (90th vs 10th percentile) was associated with 2.66 (95% CI, 2.02-3.51), 3.02 (95% CI, 2.21-4.12), 2.62 (95% CI, 1.99-3.46), and 2.79 (95% CI, 2.04-3.81) greater hazard of clinical progression in MCSA female participants who did not carry the APOE ε4 variant (ε4-), females who did carry the APOE ε4 variant (ε4+), males who were ε4-, and males who were ε4+, respectively. In ADNI, hazards were 2.67 (95% CI, 1.86-3.85), 2.83 (95% CI, 1.89-4.22), 2.08 (95% CI, 1.48-2.92), and 3.99 (95% CI, 2.59-6.13), respectively. In MCSA, higher baseline p-tau217 and older age were associated with greater absolute risk of progression. At age 75 years and assuming sex and APOE are at the MCSA means of 0.511 and 0.268, 5-year absolute risk of MCI increased from 7% (95% CI, 5%-8%) to 17% (95% CI, 13%-20%) for a p-tau217 concentration of 0.072 vs 0.324 pg/mL; 10-year absolute risk of MCI increased from 15% (95% CI, 12%-18%) to 35% (95% CI, 29%-41%; P < .001 for both). At 0.324 pg/mL, 5-year MCI risk increased from 6% (95% CI, 4%-8%) to 37% (95% CI, 32%-43%) for ages 65 to 85 years; 10-year risks were 17% (95% CI, 12%-21%) and 66% (95% CI, 57%-74%; P < .001 for both). Results were similar for p-tau217/Aβ42. Conclusions and Relevance: This study found that higher plasma p-tau217 and older age were associated with higher 5- and 10-year risk of cognitive impairment. Plasma p-tau217 concentrations, combined with age, sex, and APOE ε4 status, can enable individualized estimation of short-term absolute risk of cognitive impairment in CU individuals, with applications in prognosis and trial enrichment in preclinical AD.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
在水一方的应助被675675采纳,获得10
1秒前
幸福台灯完成签到,获得积分10
1秒前
Captainhana完成签到,获得积分10
3秒前
4秒前
嘤嘤嘤发布了新的文献求助10
5秒前
三千白发生完成签到,获得积分10
5秒前
纳古菌完成签到,获得积分10
6秒前
SG完成签到,获得积分10
6秒前
听话的无极完成签到,获得积分10
6秒前
6秒前
123456完成签到,获得积分10
7秒前
努力小人完成签到,获得积分10
7秒前
8秒前
liang完成签到,获得积分10
8秒前
8秒前
青葙完成签到,获得积分10
9秒前
123456发布了新的文献求助10
10秒前
11NING发布了新的文献求助10
11秒前
Ysk完成签到,获得积分10
11秒前
13秒前
675675发布了新的文献求助10
15秒前
汉堡包的应助被小艾同学采纳,获得10
15秒前
16秒前
19秒前
11NING完成签到,获得积分10
19秒前
19秒前
SCI完成签到,获得积分10
20秒前
Koi发布了新的文献求助10
20秒前
禹hs完成签到,获得积分10
23秒前
吱ing完成签到 ,获得积分10
24秒前
ding的应助被bbb采纳,获得10
24秒前
SCI发布了新的文献求助10
24秒前
ZeSheng完成签到,获得积分10
25秒前
26秒前
26秒前
26秒前
眠龙完成签到 ,获得积分10
27秒前
猪猪侠完成签到,获得积分10
28秒前
28秒前
28秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181658
求助须知:如何正确求助?哪些是违规求助? 9571454
关于积分的说明 21818081
捐赠科研通 7777987
什么是DOI,文献DOI怎么找? 3433508
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479568